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Abstract
Introduction: Renal resistive index (RI), determined by Doppler ultrasonography, directly reveals and quantifies
modifications in renal vascular resistance. The aim of this study was to evaluate if mean arterial pressure (MAP) is
determinant of renal RI in septic, critically ill patients suffering or not from acute kidney injury (AKI).
Methods: This prospective observational study included 96 patients. AKI was defined according to RIFLE criteria
and transient or persistent AKI according to renal recovery within 3 days.
Results: Median renal RIs were 0.72 (0.68-0.75) in patients without AKI and 0.76 (0.72-0.80) in patients with AKI
(P=0.001). RIs were 0.75 (0.72-0.79) in transient AKI and 0.77 (0.70-0.80) in persistent AKI (P=0.84). RI did not differ in
patients given norepinephrine infusion and was not correlated with norepinephrine dose. RI was correlated with
MAP (r= -0.47; P=0.002), PaO2/FiO2 ratio (r= -0.33; P=0.04) and age (r=0.35; P=0.015) only in patients without AKI.
Conclusions: A poor correlation between renal RI and MAP, age, or PaO2/FiO2 ratio was found in septic and
critically ill patients without AKI compared to patients with AKI. These findings suggest that determinants of RI are
multiple. Renal circulatory response to sepsis estimated by Doppler ultrasonography cannot reliably be predicted
simply from changes in systemic hemodynamics. As many factors influence its value, the interest in a single RI
measurement at ICU admission to determine optimal MAP remains uncertain.
Introduction
In critically ill patients, sepsis and acute kidney injury
(AKI) are very common diseases and are associated with
increased hospitalization and elevated in-hospital mor-
tality rates [1,2]. AKI is a dynamic process that evolves
from an early reversible condition to an established dis-
ease and leads to sustained renal impairment, cell death,
and delayed renal recovery [3,4]. Consequently, prompt
resuscitation of the circulation and optimal perfusion
pressure are the primary therapies for critically ill
patients with AKI. These methods are based principally
on the appropriate management of intravenous fluid
replacement and vasopressor administration under strict
hemodynamic monitoring [5].
To date, the pathogenesis of septic AKI is not comple-
tely known [6]. An increase in renal vascular resistance
(RVR), associated with reduced renal blood flow (RBF)
and, thus, potential renal ischemia has been reported
[7,8]. Conversely, some experimental studies have
demonstrated that septic AKI may be associated with
renal vasodilatation and increased RBF [9,10]. Renal
resistive index (RI), determined by Doppler ultrasono-
graphy, allows an estimation of RVR at the bedside.
Although this parameter provides interesting informa-
tion, its interpretation remains difficult in clinical practice.
In patients with septic shock, the norepinephrine (NE)-
induced increase in mean arterial pressure (MAP) from 65
to 75 mm Hg is associated with significant decreases in
RVR and RI [11]. In contrast, some authors have reported
that RI was not influenced by vasoactive drug therapy
[12,13]. Furthermore, a recent publication reported that
increased RI was associated with persistent AKI in
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critically ill patients who require mechanical ventilation
[12]. We tested the hypothesis that the relationship
between renal RI and MAP may be influenced by renal
injury. The primary objective of this study was to evaluate
whether MAP is a determinant of renal RI in septic and
critically ill patients who do or do not have AKI.
Materials and methods
Setting and patients
Approval for this non-interventional study was obtained
from our institutional review board (Comité de Protection
des Personnes Sud-Ouest et Outre Mer III, agreement
number DC2009/43, Bordeaux, France). Because data
were collected while the care of patients conformed to
standard procedures currently used in our institute,
authorization to waive informed consent for the study was
granted. From January 2010 to February 2011, patients
admitted to our 22-bed mixed medical and surgical inten-
sive care unit (ICU) from less than 24 hours for proven or
suspected infection with severe sepsis or shock according
to the American College of Chest Physicians/Society of
Critical Care Medicine classification [14] were prospec-
tively included. Non-inclusion criteria were pregnancy, age
of less than 18 years, known renal artery stenosis, known
end-stage renal disease or chronic kidney disease defined
by a glomerular filtration rate (GFR) of less than 30 mL/
minute per 1.73 m2, angiotensin-converting enzyme
inhibitor and non-steroidal anti-inflammatory treatment,
cirrhosis with hepatorenal syndrome, and a major cardio-
genic component in septic shock defined as a need for epi-
nephrine or dobutamine or both. Patients presenting
obstructive acute renal failures, assessed by echography,
were also excluded.
Study protocol
Each patient was studied within the first 24 hours after
ICU admission and after obtaining hemodynamic stabiliza-
tion defined as an MAP of greater than 60 mm Hg for
more than 1 hour without any change in the rate of cate-
cholamine infusion or fluid vascular loading. Variation in
pulse pressure by arterial catheterization (radial or
femoral) was used as a trigger for fluid challenge. NE was
the only vasopressor used in this study. Owing to the
observational nature of the study, the optimum MAP was
left to the discretion of the attending physicians. Fluid bal-
ance on inclusion day was calculated by hourly recording
of all intravenous fluid intakes (including colloids, crystal-
loids, total parenteral nutrition, or blood products) and
urinary or digestive output from each patient. The ventila-
tor respiratory settings and sedative infusion rates were
unchanged for at least 1 hour before Doppler sonography.
Sedation was given according to individual needs as
assessed by the Behavioral Pain Scale [15] and the
Sedation-Agitation Scale [16]. Renal replacement therapy
was initiated only in patients in the Failure stage of Risk,
Injury, Failure, Loss, and End-stage kidney disease
(RIFLE).
Transthoracic echocardiography and renal echocardio-
graphy were systematically performed by intensivists certi-
fied in echocardiography. A Vivid-i ultrasound machine
with a 4-MHz curved-array multifrequency transducer
was used (GE Healthcare, Little Chalfont, Buckingham-
shire, UK). The cardiac output by using the Doppler
method at the level of the left ventricular outflow tract
and renal perfusion indices were measured [17]. Intra-
renal Doppler signals were obtained from two or three
representative proximal interlobar arteries. The peak sys-
tolic velocity (Vmax) and the minimal diastolic velocity
(Vmin) were determined by pulse wave Doppler, and the RI
was calculated as (Vmax - Vmin)/Vmax [13]. The results
from three consecutive measurements on both kidneys
were averaged. The reproducibility of RI measurements
was assessed in 20 patients by two investigators (AD and
BM).
Definitions
The Simplified Acute Physiology Score II (SAPS II) and
the Sepsis-related Organ Failure Assessment score were
assessed to evaluate the severity of disease of each patient
at inclusion in the study. AKI was evaluated at inclusion
and was defined by using the consensus definition from
the Acute Dialysis Quality Initiative group, which proposes
criteria for three grades of increasing severity (risk of acute
renal failure, injury to the kidney, and failure of kidney
function) and two outcome classes (loss of kidney function
and end-stage kidney disease) (RIFLE classification). In the
absence of known baseline serum creatinine (sCr) levels,
the nadir of sCr after renal recovery was recorded to eval-
uate baseline renal function. In the absence of renal recov-
ery, baseline sCr was estimated by using the Modification
of Diet in Renal Disease (MDRD) formula. Transient AKI
was defined as AKI that resolved within 3 days after inclu-
sion by using conventional treatment in the ICU. Recovery
from AKI was defined as a 50% decrease in sCr or normal-
ization of urine output in the absence of diuretics or both.
Persistent AKI was defined as persistent elevated sCr or
oliguria (less than 0.5 mL/kg per hour) for at least 3 days
[18-21].
Statistical analyses
Continuous variables were presented as mean (standard
deviation) and median (interquartile range) for non-
Gaussian variables and were compared by the Mann-
Whitney U test. Categorical variables were presented as
number (percentage) and were compared by the Pearson
chi-squared test or Fisher exact test. Comparisons
between more than two groups were made by using
Kruskal-Wallis one-way analysis of variance with post
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hoc analysis. Intra-observer reliability and inter-observer
reliability of measurements were determined by the cor-
responding intraclass correlation coefficients and their
95% confidence intervals (CIs) [22]. Inter-observer mea-
surements were compared by a Bland and Altman ana-
lysis. Correlation tests were performed by using the
Spearman correlation coefficient. A logistic regression
was performed to identify variables significantly asso-
ciated with an RI of less than 0.75. All tests were two-
sided, and a P value of less than 0.05 was considered
statistically significant. Statistical analysis was carried
out with JMP for Windows, version 6.0 (SAS Institute
Inc., Cary, NC, USA).
Results
Ninety-six patients were prospectively screened during the
study period. Poor-quality images from two patients made
Doppler measurements for any lobar arteries impossible.
Consequently, 94 patients were included in the statistical
analyses (Table 1). Doppler measurements could be
obtained from only one kidney in 15 patients. In this case,
the right kidney has been preferentially observed (11
patients out of 15). For the 79 patients in whom bilateral
Doppler could be performed, matched t test comparisons
of right and left RI measurements showed no significant
differences: 0.73 (95% CI 0.70 to 0.76) versus 0.73 (95% CI
0.70 to 0.75). Intra-observer variation was 3.4%, and the
intraclass correlation coefficient was 0.94 (95% CI 0.92 to
0.96). Inter-observer variation was 6.2%, and the intraclass
correlation coefficient was 0.92 (95% CI 0.81 to −0.97).
The mean bias of inter-observer measurements was 0.00
(95% CI −0.10 to 0.09). RI was not correlated with cardio-
vascular risk factors and was correlated only with age in
patients without AKI (r = 0.35; P = 0.015). RI was higher
in patients presenting with an arterial partial pressure of
oxygen/fraction of inspired oxygen (PaO2/FiO2) ratio of
less than 200: 0.76 (0.72 to 0.80) versus 0.72 (0.68 to 0.78)
(P = 0.02).
For patients with transient AKI, diagnosis was made at
Risk, Injury, or Failure levels in 42%, 33%, and 25% of
cases, respectively. For patients with persistent AKI, diag-
nosis was made at Risk, Injury, or Failure levels in 7%,
11%, and 82% of cases, respectively. Median renal RIs were
0.72 (0.68 to 0.75) in patients without AKI and 0.76 (0.72
to 0.80) in patients with AKI (P = 0.001) (Table 2). Median
RIs were 0.75 (0.72 to 0.79) in cases of transient AKI and
0.77 (0.70 to 0.80) in cases of persistent AKI (P = 0.84).
RI did not differ between patients who received or did
not receive NE - respectively, 0.73 (0.69 to 0.78) versus
0.75 (0.68 to 0.78) (P = 0.94) - and was not correlated with
the NE dose (r = -0.06; P = 0.69). Among patients without
AKI, RIs were 0.73 (0.68 to 0.76) in patients who received
NE and 0.70 (0.68 to 0.75) in patients who did not receive
NE (P = 0.30) and were also not correlated with NE dose
(r = 0.20; P = 0.43).
Among patients without AKI, RI was not correlated
with fluid balance on the day of inclusion (r = 0.21, P =
0.18) or with the cardiac index (r = -0.21; P = 0.37) but
was significantly correlated with the MAP (r = -0.47;
P = 0.002) (Figure 1) and the PaO2/FiO2 ratio (r =
-0.33; P = 0.04). Among patients with AKI, RI was not
correlated with fluid balance (r = -0.15, P = 0.29), the
cardiac index (r = -0.21; P = 0.37), the MAP (r = 0.006;
P = 0.97) (Figure 2), or the PaO2/FiO2 ratio (r = -0.23;
P = 0.11). In cases of transient or persistent AKI, RI was
not correlated with the MAP (r = 0.009, P = 0.99, and
r = -0.0003, P = 0.99, respectively). When patients were
divided into three groups according to MAP, RI was
only inversely proportional to MAP in patients without
AKI (P = 0.04) (Table 3). In contrast, in cases of AKI,
RI remained elevated regardless of the MAP range.
Logistic regression, using a univariate analysis, indicated
Table 1 Characteristics of patients included in the study
(n = 94)
Variables
Male gender, mean (standard deviation) 59 (63)
Age in years, median (interquartile range) 62 (17)
Body mass index in kg/m2, median (interquartile range) 25 (22-28)
SAPS II at inclusion, median (interquartile range) 43 (33-59)
SOFA score at inclusion, median (interquartile range) 7 (3-9)
Mechanical ventilation, number (percentage) 60 (64)
ICU length of stay in days, mean (standard deviation) 14 (13)
Patients receiving norepinephrine, number (percentage) 47 (50)
Norepinephrine dose in μg/kg per minute, mean (standard
deviation)
0.37 (0.34)




Elevated cholesterol 21 (22)
Obesity and physical inactivity 9 (10)






Diuretic use, number (percentage) 20 (21)
Acute kidney injury, number (percentage) 52 (55)
Transient 24 (25)
Persistent 28 (30)
Renal replacement therapy, number (percentage) 20 (21)
28-day all-cause mortality, number (percentage) 18 (20)
ICU, intensive care unit; SAPS II, Simplified Acute Physiology Score II; SOFA,
Sepsis-related Organ Failure Assessment.
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that the factors that predicted an RI of greater than 0.75
in patients without AKI were the MAP (P = 0.02) and
SAPS II (P = 0.002).
Discussion
In this study, renal RI was evaluated in critically ill patients
with sepsis after hemodynamic stabilization. A poor corre-
lation between RI and MAP, age, or PaO2/FiO2 ratio was
found in septic and critically ill patients without AKI com-
pared with patients with AKI. Our understanding of the
pathogenesis of septic AKI is limited because currently we
do not have a clinically validated method to measure RBF.
In patients with renal hypoperfusion, compensatory
mechanisms to maintain GFR include attenuation of affer-
ent arteriolar vasoconstriction, afferent arteriolar dilation,
efferent arteriolar constriction, and neuro-/hormonal
effects to increase tubular reabsorption of fluid and main-
tenance of cardiac output [18]. An increase in RVR, repre-
senting renal vasoconstriction and a reduced RBF leading
to renal ischemia, has repeatedly been proposed to be








Mean arterial pressure, mm Hg 78 (67-86) 70 (65-87) 70 (65-87) 0.4
Heart rate, beats per minute 92 (78-105) 90 (83-120) 96 (79-117) 0.5
Fluid balance on inclusion day, mL 1,585 (837-2,612)a 1,725 (1,205-3,002) 2,650 (1,556-3,487)b 0.01
Norepinephrine dose, μg/kg per minute 0.18 (0.06-0.37)a 0.29 (0.11-0.45)a 0.48 (0.20-0.78)b,c 0.01
Cardiac index, L/minute per m² 3.1 (2.3-4.6) 3.3 (2.3-3.8) 3.1 (2.4-4.2) 1
Blood lactate, mEq/L 1.2 (0.9-2.0)a 1.5 (1.0-2.9) 2.4 (1.3-3.9)b 0.02
Hematocrit, percentage 30 (27-33) 31 (28-38) 29 (25-32) 0.3
PaO2/FiO2 ratio 240 (140-320) 240 (140-305) 180 (120-260) 0.1
Serum creatinine at inclusion, μmol/L 69 (45-81)a,c 160 (98-196)a,b 191 (134-243)b,c <0.0001
FeNa, percentage 0.5 (0.2-1)a,c 1.5 (0.6-2.4)b 2.7 (0.6-6.7)b 0.008
FeU, percentage 28 (16-39) 36 (31-45) 31 (12-46) 0.2
Resistance index 0.72 (0.68-0.75)a,c 0.75 (0.72-0.79)b 0.77 (0.70-0.80)b 0.005
Results are expressed as median (interquartile range). FeNa, fractional excretion of sodium, was calculated as [(urine sodium/plasma sodium)/(urine creatinine/
plasma creatinine)] × 100. FeU, fractional excretion of urea, was calculated as [(urine urea/plasma urea)/(urine creatinine/plasma creatinine)] × 100. P value refers
to between-group comparisons (Kruskal-Wallis one-way analysis of variance with post hoc analysis). aP <0.05 compared with persistent acute kidney injury (AKI)
group. bP <0.05 compared with no AKI group. cP <0.05 compared with transient AKI group. PaO2/FiO2, arterial partial pressure of oxygen/fraction of inspired
oxygen.
Figure 1 Relationship between resistive index (RI) and mean arterial pressure (MAP) in patients without acute kidney injury (AKI).
Correlations were assessed by using Spearman correlation coefficient.
Dewitte et al. Critical Care 2012, 16:R165
http://ccforum.com/content/16/5/R165
Page 4 of 8
central to the pathogenesis of septic acute renal failure
[7,8]. This paradigm has been derived from animal studies,
using a variety of models, and from techniques for the
measurement of RBF and for induction of sepsis without
hemodynamic support [23]. However, many studies do
not report decreased RBF in sepsis. Shortly after induced
septic shock in ewes without significant fluid resuscitation
or NE administration, Langenberg and colleagues [10]
reported marked renal vasodilatation, which led to a tran-
sient increase in RBF. In parallel, sCr significantly
increased after 24 hours whereas fractional excretion of
sodium and fractional excretion of urea decreased in the
Figure 2 Relationship between resistive index (RI) and mean arterial pressure (MAP) in patients with acute kidney injury (AKI).
Correlations were assessed by using Spearman correlation coefficient.
Table 3 Characteristics of patients according to mean arterial pressure
<70 mm Hg 70 to 85 mm Hg >85 mm Hg P value
No acute kidney injury (n = 13) (n = 19) (n = 10)
Mean arterial pressure, mm Hg 63 (59-66)a,b 79 (74-81)b,c 93 (89-100)a,c <0.001
Heart rate, beats per minute 88 (77-92)a 98 (90-115)b,c 90 (64-96)a 0.026
Fluid balance on inclusion day, mL 1,400 (865-2,735) 1,680 (990-2,560) 1,237 (699-2,376) 0.7
Norepinephrine infusion, number (percentage) 6 (46) 9 (47) 3 (30) 0.6
Norepinephrine dose, μg/kg per minute 0.20 (0.06-0.38) 0.19 (0.05-0.36) 0.17 (0.06-0.47) 0.9
Cardiac index, L/minute per m² 2.6 (1.7-3.0) 4.1 (3.1-7.8) 2.7 (1.9-5.0) 0.1
PaO2/FiO2 ratio 280 (116-310) 240 (107-302) 229 (193-395) 0.4
Resistance index 0.74 (0.70-0.78) 0.72 (0.68-0.77) 0.69 (0.67-0.72)c 0.04
Acute kidney injury (n = 25) (n = 14) (n = 13)
Mean arterial pressure, mm Hg 65 (62-66)a,b 73 (70-76)b,c 94 (89-104)a,c <0.001
Heart rate, beats per minute 95 (83-124) 90 (82-117) 89 (79-112) 0.7
Fluid balance on inclusion day, mL 2,605 (1,303-3,767) 2,650 (2,184-3,481) 1,480 (1,105-2,400) 0.1
Norepinephrine infusion, number (percentage) 16 (64) 10 (71) 3 (23) 0.02
Norepinephrine dose, μg/kg per minute 0.20 (0.06-0.38) 0.19 (0.05-0.36) 0.17 (0.06-0.47) 0.9
Cardiac index, L/minute per m² 2.8 (2.4-3.6) 3.0 (1.8-5.2) 3.7 (3.1-5.9) 0.4
PaO2/FiO2 ratio 140 (110-270) 252 (180-310) 180 (134-270) 0.06
Resistance index 0.76 (0.73.80) 0.74 (0.66-0.78) 0.78 (0.73-0.82) 0.1
Results are expressed as median (interquartile range). P value refers to between-group comparisons (Kruskal-Wallis one-way analysis of variance with post hoc
analysis). aP <0.05 compared with mean arterial pressure (MAP) 70-85 mm Hg group. bP <0.05 compared with MAP >85 mm Hg group. cP <0.05 compared with
MAP <70 mm Hg group. PaO2/FiO2, arterial partial pressure of oxygen/fraction of inspired oxygen.
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first 48 hours (as seen in pre-renal azotemia). In human
sepsis, sustained systemic vasodilatation with a high car-
diac output is the dominant clinical finding during the
early phase of AKI [24,25].
Determination of increased RI on the first day of septic
shock is known to have predictive value for acute renal
failure in septic shock [13]. Darmon and colleagues [12]
recently confirmed these results in patients who required
mechanical ventilation. A Doppler renal RI value of more
than 0.795 also predicted persistent AKI with good sensi-
tivity and specificity. Our study has confirmed that RI is
increased in cases of AKI, particularly in cases of persis-
tent AKI. However, we were not able to precisely distin-
guish transient from persistent AKI in our selected
patients. We assume that hypoperfusion (pre-renal com-
ponent) and injury (renal component) often occurred at
the same time in injured kidneys given that each tubular
injury is a continuum from volume responsiveness to
necrosis. The definition of pre-renal azotemia has con-
ceptual or diagnostic limitations or both, and a precise
renal RI cutoff point to distinguish clinical entities was
difficult to determine in this study.
Alterations in renal hemodynamics may be induced by
multiple factors in critically ill patients. Improving regio-
nal perfusion and inducing excessive vasoconstriction
must be balanced when NE therapy is required. Indeed,
intra-renal infusion of NE is used to induce AKI in ani-
mals, and NE has been shown to decrease RBF in healthy
volunteers. In contrast, too low a dose of NE in patients
with vasodilatory shock may result in an MAP that is
below the limit of renal autoregulatory capacity. Guide-
lines for hemodynamic support of adult patients with
sepsis advocate that vasopressors be titrated to the mini-
mum level required to provide effective organ perfusion
[26]. To prevent AKI, maintaining an MAP of at least 60
to 65 mm Hg during vasodilatory shock has also been
recommended [27].
Deruddre and colleagues [11] suggested that measuring
renal RI could help optimize renal perfusion in critically
ill patients. In that study, a significant decrease in renal
RI was observed in 11 patients with septic shock when
MAP was increased from 65 to 75 mm Hg by NE titra-
tion. However, measurements of renal RI remain difficult
to interpret in clinical practice. Our findings confirm pre-
vious results, showing that RI is dependent on factors
apart from NE infusion [12,13]. In patients with acute
lung injury, low oxygenation levels have been reported to
increase renal RI [28]. In our study, RI was inversely cor-
related with the PaO2/FiO2 ratio in patients without AKI.
Recently, Darmon and colleagues [12] also found a signif-
icant negative correlation between MAP and RI in criti-
cally ill patients receiving mechanical ventilation (see
Online Supplementary Material). However, in that study,
MAP was not statistically different between patients
without AKI and patients with transient or persistent
AKI, despite an increasing RI.
Our study has reported that RI is inversely correlated
with MAP in septic critically ill patients without AKI but
not in patients with AKI. This may have been because of
unresponsive renal vasoconstriction or renal vascular
obstruction caused by a sustained kidney injury, despite
hemodynamic support, which led to increased RI. On the
other hand, in septic critically ill patients without AKI, an
inverse correlation might reflect increased renal perfusion
pressure with associated reduced activation of RVR,
reflected by RI, leading to pressure-dependent renal perfu-
sion. Sepsis or sedation could explain this modified renal
vasomotor response in our patients. However, this associa-
tion seems to be relatively poor. Indeed, the correlation
coefficient that we found between RI and MAP means
that most of the changes in RI lie somewhere other than
MAP. Consequently, renal circulatory response to sepsis
estimated by Doppler ultrasonography cannot be reliably
predicted simply from changes in systemic hemodynamics.
This finding is consistent with a recent study showing that
the development of septic AKI often seems to be accom-
panied by an uncoupling between systemic vascular resis-
tance and RVR [29].
The following points need to be considered when
assessing the clinical relevance of our study. First, this
study was purely observational as it was difficult to per-
form a blinded study. Second, the present study included
a single-center population of patients who had developed
vasodilatory shock. Patients exhibiting an important car-
diogenic component of septic shock, defined by the need
for epinephrine or dobutamine or both, were deliberately
excluded. Third, the pressure of the renal interstitium
was impossible to measure in clinical practice, and renal
Doppler measurements do not reflect microcirculation
vessel tone. In addition, measurement of GFR and renal
oxygenation by continuous renal vein thermodilution
was not conducted, as we were unable to use invasive
hemodynamic monitoring in this observational study. No
patient included in this study presented clinical intra-
abdominal hypertension, but this was not assessed by
intravesical measurement. Other confounding factors not
identified in this study also may have influenced our
results. Finally, the subjective part of renal ultrasound
and the precision of measurements, assessed by the inter-
observer variation in comparison with the Doppler mea-
surement differences, are the main limitations when
determining renal RI.
Although future AKI studies need to determine the
impact of early recognition of pressure-dependent renal
perfusion on renal recovery, the timing of volume replace-
ment to facilitate early restoration of kidney perfusion and
to optimize vasopressor infusion dose can be an important
determinant in preventing the progression of AKI and
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facilitating recovery. Estimating renal circulatory response
to sepsis by Doppler ultrasonography can be hazardous
because many factors influence RI value. Increased RI may
be associated with low renal perfusion pressure or low
oxygenation levels in patients without AKI but may also
be associated with sustained renal injury. Thus, its value in
septic critically ill patients in the ICU should be inter-
preted carefully before concluding that there is renal injury
or estimating optimal MAP.
Conclusions
A poor correlation between renal RI and MAP found only
in septic and critically ill patients without AKI suggests
that determinants of RI are numerous. Consequently,
renal circulatory response to sepsis estimated by Doppler
ultrasonography cannot reliably be predicted simply from
changes in systemic hemodynamics. The value of a single
RI measurement at ICU admission to determine optimal
MAP remains uncertain.
Key messages
• RI, measured by Doppler ultrasonography, is corre-
lated to MAP, age, and PaO2/FiO2 ratio only in sep-
tic and critically ill patients without AKI.
• RI was increased in cases of AKI, but theses corre-
lations were abolished.
• RI did not differ between patients who received or
did not receive NE and was not correlated with the
NE dose.
• This correlation between RI and MAP in septic
and critically ill patients without AKI is poor, sug-
gesting that the determinants of RI are numerous.
• A single RI measurement at admission of septic
critically ill patients to predict persistent AKI or to
determine optimal MAP seems insufficient.
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